Keyphrases
Randomized Controlled Trial
100%
Estradiol
100%
Transgender
70%
Gender-affirming Hormone Therapy
56%
Diabetes Mellitus in Pregnancy
50%
Role of Technology
50%
Expert Review
50%
Diabetes Management
50%
Transgender Females
50%
Sublingual
44%
17β-estradiol
35%
Once-daily
34%
Twice Daily
34%
Testosterone Suppression
29%
Type 1 Diabetes Mellitus (T1DM)
25%
Glucose-insulin System
25%
Insulin Pump
25%
Transdermal
24%
17-estradiol
22%
Testosterone
14%
Total Testosterone
14%
Spironolactone
14%
Antiandrogen
14%
Individualized Counseling
12%
Pumping Technology
12%
Telehealth Platform
12%
Short-range Wireless
12%
Patient Visits
12%
Patient Autonomy
12%
Continuous Glucose Monitor
12%
Blood Glucose Monitoring
12%
Nutrition Counseling
12%
Pregnant Women
12%
Insulin Administration
12%
Pregnancy Complications
12%
Telehealth
12%
Multiple Daily Insulin Injections
12%
Perinatal Outcome
12%
Wireless Technology
12%
Carbohydrate Intake
12%
Routine Management
12%
Automated Features
12%
Glycemic Control
12%
Hybrid Closed Loop
12%
Remote Patient Monitoring
12%
Glycemic Monitoring
12%
Adverse Perinatal Outcomes
12%
Smartphone Application
12%
Continuous Glucose Monitor Use
12%
Patient Satisfaction
12%
Pharmacology, Toxicology and Pharmaceutical Science
Diethylstilbestrol
100%
Randomized Controlled Trial
100%
Endocrine Therapy
51%
Transdermal
16%
Spironolactone
12%
Antiandrogen
12%
Blood Clotting Factor
10%
Route of Administration
7%
Protein S
5%
Liver Disease
5%
Cigarette Smoking
5%
Blood Clotting Factor 9
5%
Gonadorelin Agonist
5%
Randomized Clinical Trial
5%
Adverse Event
5%
Von Willebrand Factor
5%
Blood Clotting Disorder
5%
Blood Clotting Factor 11
5%
Protein C
5%
Activated Protein C Resistance
5%
Insulin Resistance
5%
Prothrombin
5%
Lipoprotein
5%
Dyslipidemia
5%